medRxiv preprint doi: https://doi.org/10.1101/2021.04.25.21255897; this version posted April 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

1
2

Contrasting epidemiology and population genetics of COVID-19 infections defined with
74 polymorphic loci in SARS-CoV-2 genomes sampled globally.

3
4
5
6
7
8
9
10

Felicia Chan1,2, Ricardo Ataide3,4, Jack S. Richards2,3,5 and Charles A. Narh2,3,5*

11

*Correspondence: Charles A. Narh

12

charles.narh@burnet.edu.au

13

Short running title: Genetic tool for monitoring SARS-CoV-2 infections.

14
15

Keywords: COVID-19, SARS-CoV-2, epidemiology, genetics, multilocus-genotypes,
evolution, linkage, mutation and transmission.

16

Abstract

17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38

SARS-CoV-2, the coronavirus causing COVID-19, has infected and killed several millions of
people worldwide. Since the first COVID-19 outbreak in December 2019, SARS-CoV-2 has
evolved with a few genetic variants associated with higher infectivity. We aimed to identify
polymorphic loci in SARS-CoV-2 that can be used to define and monitor the viral
epidemiology and population genetics in different geographical regions. Between December
2019 and September 2020, we sampled 5,959 SARS-CoV-2 genomes. More than 80% of the
genomes sampled in Africa, Asia, Europe, North America, Oceania and South America were
reportedly isolated from clinical infections in older patients, â‰¥ 20 years. We used the first
indexed genome (NC_045512.2) as a reference and constructed multilocus genotypes (MLGs)
for each sampled genome based on amino acids detected at 74 polymorphic loci located in
ORF1ab, ORF3a, ORF8, matrix (M), nucleocapsid (N) and spike (S) genes. Eight of the 74
loci were informative in estimating the risk of carrying infections with mutant alleles among
different age groups, gender and geographical regions. Four mutant alleles - ORF1ab L4715, S
G614, and N K203 and R204 reached 90% prevalence globally, coinciding with peaks in
transmission but not COVID-19 severity, from March to August 2020. During this period, the
MLG genetic diversity was moderate in Asia, Oceania and North America; in contrast to
Africa, Europe and South America, where lower genetic diversity and absence of linkage
disequilibrium indicated clonal SARS-CoV-2 transmission. Despite close relatedness to Asian
MLGs, MLGs in the global population were genetically differentiated by geographic region,
suggesting structure in SARS-CoV-2 populations. Our findings demonstrate the utility of the
74 loci as a genetic tool to study and monitor SARS-CoV-2 transmission dynamics and
evolution, which can inform future control interventions.

1

Central Clinical School, Monash University, Melbourne, Australia.
Burnet Institute for Medical Research, VIC 3004, Melbourne, Australia.
3
Department of Medicine, University of Melbourne, Australia.
4
Walter and Eliza Hall Institute, Melbourne, Australia
5
Departmet of Infectious Diseases, Monash University, Melbourne, Australia.
2

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2021.04.25.21255897; this version posted April 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

39

Introduction

40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81

Knowledge of the epidemiology and transmission dynamics of SARS-CoV-2, the causative
agent of the COVID-19 pandemic, is seminal to public health control efforts. SARS-CoV-2
has more than 110 million confirmed cases â€“ which resulted in 2.5 million deaths â€“ as of March
2021. Since the first outbreaks in China in December 2019, SARS-CoV-2 transmission
hotspots have shifted spatio-temporally from Asia to Europe, followed by North America and
South America [1, 2]. Testing and isolation of infected individuals have been integral, as public
health interventions, to control the virus' spread. Global reports have shown significant
differences in the prevalence, distribution and demographics of COVID-19 cases; however,
little is known about how these epidemiological differences relate to infection dynamics.
SARS-CoV-2 is a beta-coronavirus with a positive single-stranded RNA genome of ~30 kb. It
shares 80% of its genome with SARS-CoV, which caused the 2003-2004 SARS outbreak [3].
A prominent structural feature is the spike glycoprotein (S), which facilitates cell entry and is
a target of host immune responses. Other structural proteins include the nucleocapsid (N),
envelope (E) and matrix/membrane (M) proteins, which are involved in viral assembly and
priming of host immune responses [4]. Nearly half of the genome comprises an opening reading
frame 1ab (orf1ab), which encodes 16 non-structural proteins (NSP 1-16) that constitute the
replicase machinery. Notable NSPs include NSP1 (suppresses host immune responses), NSP5
(encodes viral 3C-like protease) and NSP12 (encodes the RNA-dependent RNA polymerase,
i.e., RdRP). Other ORFs, including ORF3a (induces apoptosis in host cells), ORF6, ORF7a,
ORF8 (ORF8 mediates immune suppression and evasion) and ORF10 encode accessory
proteins that are involved in viral replication and host immune dysregulation [4].
Since first being identified, the virus has evolved, with numerous genetic variants being
associated with higher infectivity. The geographical distribution and probable risk factors (e.g.,
demographics and clinical factors) for infection with mutant genotypes remain unknown.
Comparative genomic analysis of SARS-CoV-2 infections collected globally suggests that the
virus is adapting to its human host. A few genetic variants harbouring E484K, N501Y and
D614G mutations in the S protein have been associated with higher infectivity than the wildtype variant, Wuhan NC_045512.2 [5, 6]. Variants with these mutations rose to predominance
in many parts of the United Kingdom and South Africa [7, 8]. Other mutations, including
orf1ab P4715L, Orf3a G251V and orf8 L84S, have been associated with higher infectivity and
viral density, respectively [9]. Whether these and other unreported mutations are linked, under
selection and can be used to source-track infections within and between different geographical
regions has not been investigated.
More polymorphic and informative loci, representative of the global SARS-CoV-2 genetic
diversity, are needed to accurately differentiate closely related variants and interrogate the virus
population genetics in different geographical regions [9, 10]. Comparison of SARS-CoV-2
whole genomes identified phylogenetic clusters, defined by Single Nucleotide Polymorphisms
(SNPs) in < 10 codons/loci, that differentiated European and Asian infections [11, 12];
however, these loci lacked the needed resolution to differentiate variants circulating globally.

medRxiv preprint doi: https://doi.org/10.1101/2021.04.25.21255897; this version posted April 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

82
83
84
85
86
87

Multilocus genotyping using amino acid changes in SARS-CoV-2 can reduce the complexity
in the genomic data and provide informative and virologically relevant data that can provide
insights into the transmission dynamics and evolution of variants causing COVID-19. This
approach on multiple polymorphic loci can estimate and monitor the genetic diversity of
SARS-CoV-2 populations spatiotemporally and in response to control interventions.

88
89
90
91
92
93
94
95
96

This study evaluated the epidemiology and population genetics of 5,959 SARS-CoV-2
genomes sampled globally to identify risk factors associated with infection with mutant
variants and gain insights into how the viral population had evolved geographically eight
months into the pandemic. Briefly, we identified 74 polymorphic loci, of which eight loci
located in orf1ab, orf3a, orf8, N and S genes, were considered informative in explaining the
risk of infection with mutant variants among different demographics and COVID-19 disease
phenotypes. Multilocus genotyping at the 74 loci allowed us to genetically differentiate closely
related variants circulating globally and gain insights into the viral population genetics in
different geographical regions.

97

medRxiv preprint doi: https://doi.org/10.1101/2021.04.25.21255897; this version posted April 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

98

Material and Methods

99
100
101
102
103
104
105
106
107
108
109
110

Data curation and study variables. The current study sought to investigate the epidemiology
and population genetics of SARS-CoV-2 genetic variants causing the COVID-19 pandemic. It
was conducted retrospectively by analyzing SARS-CoV-2 whole genomes of ~30 kb. These
genomes were isolated from human infections - asymptomatic and symptomatic. From
December 2019 to September 2020, a total of 5,959 complete genomes with their associated
clinical and patient data were retrieved from the Global Initiative on Sharing Avian Influenza
Data (GISAID) database [13]. The demographic data included age (grouped into four
categories: 0 â€“ 19, 20 â€“ 39, 40 â€“ 59 and â‰¥ 60 years), gender and the geographical region
(continent) where the infection was diagnosed. The associated metadata included clinical
outcomes - asymptomatic (no symptoms) or symptomatic (mild or severe/critical). Other
metadata included specimen type - upper respiratory tract (URT) or lower respiratory tract
(LRT) and the technology/chemistry used to sequence the viral genome.

111
112
113
114
115
116
117
118
119
120
121

Sequence alignments and selection of polymorphic loci. The genomes were aligned to the
Wuhan reference strain (NC_045512.2) using minimap version 2.17, and the SNPs, including
the corresponding amino acid changes, were called using the Geneious Prime SNP caller [14,
15]. Amino acids identical to the reference strain at the investigated loci were considered wildtype; else, they were considered mutants. Only polymorphic (â‰¥ 2 alleles, i.e. amino acids,
including the wild-type) loci with a minor allele frequency (MAF) of 0.01 were retained and
analyzed in this study. These criteria were implemented to ensure unbiased construction of
haplotypes (within a gene) and multilocus genotypes, i.e. MLGs (across â‰¥ two genes) [16]. An
allele was designated by the amino acid followed by the codon (referred hereafter as locus)
number. E.g. S D614 and S G614 indicate glutamine (wild-type allele) and glycine (mutant allele)
at locus/codon 614 of the S protein.

122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137

Population genetics. Genetic diversity indices â€“ the number of haplotypes or MLGs, eMLGs
(normalized MLG based on smallest sample) and expected heterozygosity (He) were estimated
using poppr V2.8.5 [16]. The eMLG was then plotted using the R package Vegan [17], as a
rarefaction curve to estimate the depth/richness in sampling. The evenness (E5) statistic was
used to evaluate whether the haplotypes or eMLGs found within the population were evenly
distributed. Its score ranges from 0 (presence of predominant haplotypes or MLGs) to 1
(haplotypes or MLGs are evenly distributed). The He is a measure of genetic diversity, scoring
from 0 (no genetic diversity, i.e., genomes carry the same haplotype or MLG) to 1 (complete
diversity, i.e., genomes carry unique haplotypes or MLGs).
To determine linkage disequilibrium (LD), i.e., non-random association of alleles at two or
more loci, the standardized index of association (ð‘ŸÌ…d) was estimated using poppr. The presence
of genomes with identical MLGs, i.e. clones within a population, can overestimate the LD [18].
To account for this, the LD was clone-corrected using the dataset consisting of unique MLGs.
To determine whether the LD was â€˜structuredâ€™ between specific gene pairs, a pairwise LD was
performed as described elsewhere [19]. The ð‘ŸÌ…d score ranges from 0 to 1, with 0 indicating no
4

medRxiv preprint doi: https://doi.org/10.1101/2021.04.25.21255897; this version posted April 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163

LD and 1 indicating complete LD. The statistical significance of the score was supported by a
P-value < 0.05.
Genetic differentiation (Neiâ€™s GST) among MLG populations within and between continents
was estimated using mmod [20]. The GST score ranges from 0 (no genetic differentiation, i.e.,
populations are similar or have identical MLGs) to 1 (i.e., complete genetic differentiation, i.e.,
populations are dissimilar or have unique MLGs); values ranging from 0 to 0.09, 0.1 to 0.19
and â‰¥ 0.2 indicate little, moderate and great genetic differentiation, respectively [21]. We then
performed a Discriminant Analysis of Principal Components (DAPC) â€“ a multivariate
method for identifying genetic clusters of closely related MLGs [22]. Briefly, the global MLG
dataset was trained on a K-means algorithm, implemented in adegenet [22] to identify the
optimum number of genetic clusters within the global population. The DAPC was then
performed on the genetic clusters retained during a PCA by maximizing the genetic variance
between populations while minimizing the variance within populations [23]. The DAPC
assigned population membership probability to each MLG, which was plotted using ggplot2
[24]. To visualize the genetic relationships and clonal complexes among the MLGs, the
goeBURST FULL MST algorithm implemented in Phyloviz V2 was used to construct networks
of minimum-spanning trees [25].
Statistical analysis. Statistical analysis was performed in R v3.5.2 [26] and STATA v16 [27].
Proportions were compared using the chi-square or Fisherâ€™s exact test. Multiple testing was
adjusted using the Holm-Bonferroni method. Logistic regression was performed to determine
the association between the study variables and the odds of harbouring a mutant allele. Age,
geographical region, and gender were considered possible confounders and adjusted for in the
final model. The adjusted odds ratio (OR) was considered statistically significant for all
analysis where the P-value was < 0.05.

164
165

5

medRxiv preprint doi: https://doi.org/10.1101/2021.04.25.21255897; this version posted April 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

166

Results and discussion

167
168
169
170
171
172
173
174
175
176
177

Demographics of the study population. The majority of the SARS-CoV-2 whole genomes
we sampled (N=5,959) from GISAID between December 2019 and September 2020 were
reportedly from Asia (26.5%), Europe (19.9%) and Oceania (27.6%), with â‰¤ 10% each being
from Africa, North America and South America (Table 1). Despite significant differences (Pvalue â‰¤ 0.005) in the proportion of genomes sampled for the study variables, > 35.0% of the
genomes sampled in Africa and Oceania were reportedly from the 20 -39 years age group. In
contrast, the majority of genomes (> 31.0%) from the rest of the world were reportedly from
the 40 â€“ 59 years age group (Table 1, S1 and S2). These data are consistent with the age
disparities in COVID-19 cases [28, 29]. Except in Africa, where a significantly higher
proportion of genomes were isolated from females (56.2%, P-value = 0.002), most were
reportedly isolated from males.

178

Table 1. Demographics of the study population
Factor
Age
group#
(years)
Gender#

Clinical#
Severity

Category
0 â€“ 19
20 â€“ 39
40 â€“ 59
60+
Females
Males
Asymptomatic
Mild
Severe
Missing data*

Global
5959

Africa
601

Asia
1579

Europe
1188

N.America
597

Oceania
1646

S.America
348

323 (5.4)
2054 (34.5)
1996 (33.5)
1586 (26.6)
2664 (44.7)
3295 (55.3)
60 (1.5)
557 (14.1)
3321
(84.33)
2021

68 (11.3)
276 (45.9)
185 (30.8)
72 (11.9)
338 (56.2)
263 (43.8)
0 (0.0)
15 (2.5)

123 (7.8)
559 (35.4)
561 (35.5)
336 (21.3)
581 (36.8)
998 (63.2)
41 (2.7)
134 (8.8)

43 (3.6)
273 (22.9)
389 (32.7)
483 (40.7)
581 (48.9)
607 (51.1)
18 (1.9)
64 (6.7)

20 (3.6)
196 (32.8)
217 (36.4)
164 (27.5)
250 (41.9)
347 (58.1)
0 (0.0)
282 (47.2)

58 (3.5)
634 (38.5)
515 (31.3)
439 (26.7)
754 (45.8)
892 (54.2)
0 (0.0)
2 (12.5)

11 (3.2)
116 (33.3)
129 (37.1)
92 (26.4)
160 (45.9)
188 (54.0)
1 (0.4)
60 (24.9)

586 (97.5)

1356(88.6)

870 (91.4)

315 (52.8)

14 (87.5)

180 (74.7)

0

48

236

0

1630

107

179
180
181
182

# denotes number of genomes and the percentage, N (%). * denotes the number of genomes
with missing clinical data and this was not included in the percentage calculations. N. America
(North America) and S. America (South America).

183
184
185
186
187
188
189
190
191
192

The majority of the SARS-CoV-2 genomes were reportedly isolated from throat swabs
and were sequenced using Illumina. Half of the genomes we analyzed had the associated
data on the specimen type collected for diagnosis or isolating the virus genome. URT
specimens constituted 92.0%. Of these, throat swabs were the majority (65.1%) (Figure S2).
This was observed for all the study variables (Figure S3-S5) except in South America, where
more than 60.3% of the genomes were isolated from nose swabs (Figure S4). Globally, more
than 68.0% of the genomes we sampled were reportedly sequenced using Illumina except in
Asia and South America, where a higher proportion of genomes were reportedly sequenced
using Ion Torrent (39.53%) and Nanopore (43.10%), respectively (Figure S6).

193
194
195

Seventy-four polymorphic loci were selected for multilocus genotyping of SARS-CoV-2
genomes. The majority of mutations in SARS-CoV-2 variants have been considered neutral,
i.e. associated with demographic processes [30, 31]. A few others, considered homoplasic
6

medRxiv preprint doi: https://doi.org/10.1101/2021.04.25.21255897; this version posted April 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238

(recur independently) and adaptive (associated with viral transmissibility and/or
pathogenicity), have been detected in clinical infections circulating worldwide [9, 31, 32].
Based on these reports and our filtering criteria of a MAF â‰¥ 0.01, 74 polymorphic loci (â‰¥ 2
alleles) were used to construct the MLGs (Figure S7). These loci are located within ORF1ab â€“
NSP1, NSP2, NSP3, NSP4, NSP5, NSP8, NSP12, NSP13 and NSP14, two accessory proteins
- ORF3a and ORF8, and three structural proteins - M, N and S (Table S3). The moderate genetic
differentiation (Gst = ~0.10) observed for these loci demonstrate their utility as markers for
differentiating SARS-CoV-2 variants (Table S4). The orf1ab gene was the most polymorphic
loci (Table S3-S4), indicating a mutational hotspot in SARS-CoV-2 [33]. However, its low He,
â‰¤ 0.44, compared to the moderate-to-high He, â‰¥ 0.5, in the orf3a, S and N genes is consistent
with previous reports using nucleotide data [34]. Furthermore, our data also suggest that most
mutations in the orf1ab were not under strong selection compared to those in the accessory and
structural genes [30, 31, 35]. Indeed, B cell epitopes on the N and S proteins were shown to be
highly diversified, allowing the virus to evade host immune responses [36].

The spatiotemporal selection of variants carrying mutant alleles - ORF1ab L4715, S G614,
and N K203 and R204 was associated with spikes in COVID-19 cases. Of the 149 mutant
alleles detected among the 74 loci (Figure S8-S10 and Table S4), eight alleles (Figure 1) were
considered putatively adaptive, having been previously associated with infectivity,
pathogenesis and host immune dysregulation [4]. The first four - ORF1ab L4715 (located in
NSP12/RdRP), S G614, and N K203 and R204 rose sharply in frequency from < 6% in February
to > 90% in August. This rise was associated with significant peaks in global COVID-19 cases
between March and September (Figure 1) [37]. The remaining four alleles, including ORF1ab
I265 (NSP1), ORF1ab F3606 (NSP5), ORF8 S84 and ORF3a H57, were detected â€˜transientlyâ€™ at a
lower frequency, ranging from 4 to 35% (Figure 1 and Figure S8-S10). In contrast, most of the
remaining 141 alleles circulated at a lower frequency, < 25%, and were not detected throughout
the study period and in all continents (Figure S8-S10 and Table S4). These alleles, particularly
those in the ORF1ab, have been considered neutral [31]. It is worth noting that the N501Y
mutation in the S protein, associated with higher infectivity among UK and South African
variants [5, 6], was carried by 0.8% of the genomes we sampled from Australia, Oceania. These
genomes were reportedly isolated in June, suggesting that the S Y501 allele emerged earlier than
previously reported [38].

The risk of harbouring a mutant allele varied with age, gender, geographical region and
COVID-19 phenotype. A critical gap in the surveillance of SARS-CoV-2 infections and
understanding COVID-19 clinical severity is the lack of data on the relationship between
SARS-CoV-2 variants causing clinical infections and the clinical and demographic factors of
infected individuals. To investigate this, we estimated the risk of harbouring a wild-type versus
mutant allele at eight informative loci among our study variables. These informative loci â€“
ORF1ab (265, 3606 and 4715), ORF3a 57, ORF8 84, N (203 and 204) and S 614 had alleles
that were evenly distributed (E.5 score â‰¥ 0.6) in the global population and recurred throughout
the study period (Figure 1 and Table S3).
7

medRxiv preprint doi: https://doi.org/10.1101/2021.04.25.21255897; this version posted April 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

239
240
241
242
243
244
245
246
247
248
249
250
251

Briefly, the risk of harbouring a mutant allele was associated with age, gender and COVID-19
phenotype in all the six continents (Figure 2). Compared to patients below 20 years, patients
aged 20+ years had a higher risk of harbouring mutant alleles at four loci - N 203 and 204
(Asian males), ORF3a 57 (Europe) and ORF8 84 (North America) (Figure 2). This risk among
the 20+ years cohort was maintained at the S 614 locus for patients in Oceania but not in North
America. Host immune responses to the accessory and structural proteins have been implicated
as drivers of SARS-CoV-2 evolution, with immune responses of older patients associated with
infections carrying mutant alleles [39]. Interestingly, compared to asymptomatic cases, severe
cases in Africa, Asia and North America were more likely to harbour the S D614 allele (Figure
2). Although the S G614 has been associated with enhanced viral transmission, our data indicates
that it was not associated with severe COVID-19 as reported elsewhere [40].

252
253
254
255
256
257
258

The majority of SARS-CoV-2 MLGs within each continent were detected except in Asia
and Oceania. A major hurdle to tracking the spread and understanding the evolution of SARSCoV-2 is the complexity and close relatedness of infecting genomes within and between
different geographical regions. Therefore, we utilized the 74 polymorphic loci to differentiate
the 5,959 genomes by constructing MLGs. We then used the MLG data to measure the richness
in our sampling and to interrogate the population genetics of SARS-CoV-2 at the global and
continental levels.

259
260
261
262
263
264
265
266
267
268
269
270
271
272

The MLGs were moderately distributed, as indicated by the E.5 score ranging from 0.41 for
Europe to 0.60 for South America. Asia and Oceania had the highest number of observed (â‰¥
181) and expected (â‰¥ 77) unique MLGs (Table S5). South America had the lowest number, 40
(Table 3 and S6). The plateauing of the rarefaction curve for Africa, Europe and the Americas
indicated that no new MLGs were detected with further sampling in these populations (Figure
3A). In contrast, the steep rise in Asia and Oceania's curve suggested that we had undersampled and therefore did not capture most of the MLGs within these populations. As indicated
by the positive correlation (r = 0.94, P-value = 0.017) between sample size and MLG
abundance, deep sampling is critical for detecting most SARS-CoV-2 variants causing
COVID-19 in affected communities. However, detecting most variants may be challenging in
situations where logistics for COVID-19 testing are inadequate. Indeed, < 2% of the genomes
we sampled were reportedly isolated from patients with asymptomatic infections. Considering
that asymptomatic infections constitute ~80% of all COVID-19 cases and refuel and sustain
the virus's transmission worldwide [41], they must be included during surveillance.

273
274
275
276
277
278
279
280

Linkage structures in SARS-CoV-2 populations vary among geographical regions. We
investigated the possibility that specific alleles could be linked and contribute to SARS-CoV2 fitness, including transmissibility and pathogenicity. We first quantified the genetic diversity
of SARS-CoV-2 populations in the different geographical regions. The multilocus genetic
diversity was lowest in South America (He = 0.15) and highest in Asia, North America and
Oceania (He â‰¥ 0.26) (Table 2). Our data is consistent with previous reports indicating that
SARS-CoV-2 phylogenies in the latter two regions depicted the diversity that existed
worldwide as of July 2020 [37, 42, 43]. There was significant genome-wide LD (non-random
8

medRxiv preprint doi: https://doi.org/10.1101/2021.04.25.21255897; this version posted April 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

281
282
283
284
285
286

association among alleles) both at the global and continental levels (ð‘ŸÌ…d â‰¥ 0.034, P-value <
0.001) (Table 2). However, the decay of this LD (ð‘ŸÌ…d â‰¤ 0.007, P-value â‰¥ 0.166) in Africa, Europe
and South America after repeating the analysis with the unique MLGs was indicative of clonal
SARS-CoV-2 transmission in these geographical regions. Indeed, multiple outbreaks in Europe
and South America were due to local transmissions and were largely associated with clusters
of closely related infections [43, 44].

287
288
289
290
291
292
293
294
295
296
297
298
299

Interestingly, we observed that the genome-wide LD was driven by specific gene pairs, i.e.,
â€˜structureâ€™. We detected the strongest LD signal (ð‘ŸÌ…d â‰¥ 0.3, P-value < 0.001) between NSP12
and S, NSP1 and ORF3a, NSP4 and ORF8, and NSP4 and N (Figure 3B and Figure S12),
consistent with previous reports using nucleotide data [39]. While the former three LD
structures either decayed or were maintained at the continental level, the NSP12 and S LD
structures were consistently prominent in all the geographical regions (Figure S11). A probable
driver of the NSP12-S LD structure could be the strong co-selection of the orf1ab L4715 and S
G614 alleles, which putatively enhance viral replication and infectivity, respectively [45]. Our
findings imply that the evolutionary pressures shaping the virus vary in different geographical
regions - with public health interventions, demographic factors, and host immune responses
being the most likely key drivers [39, 46, 47]. Nonetheless, it is worth noting that these LD
structures may change as the virus continues to evolve, underscoring the need for continuous
genomic surveillance.

300

Table 2: Genetic diversity estimates for SAR-COV-2 populations circulating globally.

301
302
303
304

Continent

N

MLGs

eMLGs (SE)

E.5

He

ð‘ŸÌ…d (P-value)

ð‘ŸÌ…d-cc (P-value)

Africa

601

74

56.4 (3.1)

0.57

0.19

0.034 (0.001)

0.007 (0.230)

Asia

1579

185

78.1(5.2)

0.48

0.26

0.080 (0.001)

0.022 (0.001)

Europe

1188

97

53.2 (3.8)

0.41

0.18

0.082 (0.001)

0.009 (0.166)

N.America

597

69

48.6 (3.3)

0.47

0.30

0.219 (0.001)

0.065 (0.001)

Oceania

1646

181

77.5 (5.0)

0.45

0.30

0.082 (0.001)

0.020 (0.001)

S.America

348

40

40.0 (0.0)

0.60

0.15

0.080 (0.001)

0.007 (0.278)

Total

5959

472

95.3 (5.8)

0.34

0.26

0.079 (0.001)

0.019 (0.001)

The number of observed MLGs was normalized by the smallest sample size to obtained the
expected MLGs (eMLGs) with the standard error (SE). The standardized index of association
(ð‘ŸÌ…d) was clone-corrected (ð‘ŸÌ…d-cc) using the unique MLGs dataset. N. America (North America)
and S. America (South America).

305
306
307
308
309
310

SARS-CoV-2 MLGs in Asia and Oceania were representative of the global MLG
population. The minimum spanning tree (Figure 4A) was drawn to visualize the network
relationships among the 472 unique MLGs. Here, at least 11 major clusters, including eight
global clusters (GC1 to 8), were identified. Nearly all clusters comprised a considerable number
of Asian MLGs (Figure 4A), indicative of admixture populations, as shown in Figure 4B. The
9

medRxiv preprint doi: https://doi.org/10.1101/2021.04.25.21255897; this version posted April 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

311
312
313
314
315
316
317
318
319
320
321
322
323

majority of MLGs in each continent were predicted to have 20-50% geographical assignment
to Asia and Oceania (Figure 4B). This data suggests that the majority of SARS-CoV-2 variants
in the world are of Asian descent. It also supports contact tracing data that showed that most
SARS-CoV-2 cases during the early (March to May) stages of the pandemic were linked to
imported cases from Asia [48]. However, a few MLGs were unique to each continent, as
indicated by the 40-60% within-continent membership assignments. Prominent among
continental clusters were the AC1 and OC1 clusters, detected in Asia and Oceania, respectively
(Figure 4A). The ~60% membership assignment of African MLGs to Europe (Figure 4B)
suggested that most African infections were more likely to have been imported from Europe,
contradicting previous reports of an American source based solely on travel data [49, 50]. This
underscores the need to build strong surveillance systems utilizing both travel and genomic
data.

324
325
326
327
328
329
330
331
332
333

SARS-CoV-2 MLGs were genetically differentiated within and between continents. We
detected many mutant alleles restricted to each continent (Table S6), suggesting geographical
structuring in SARS-CoV-2 populations. Asia had the highest number of unique (?) alleles, 19
in total, including ORF1ab D1812, P676, G2586 and I6297, being detected in 7.4, 4.5, 3.1 and 2.8%,
respectively of genomes sampled. Among the 16 private alleles detected in Oceania, ORF1ab
S271 (4.4%) was predominant. Europe had 12 private alleles with S G320 (10.7%) being
predominant, while ORF3a S251 (5.4%) was predominant among eight private alleles detected
in North America. Nine private alleles, including ORF1ab H4080 (15.6%) and N L187 (8.5%),
were detected in Africa. Only two private alleles â€“ ORF3a A165 (0.6%) and ORF8 A62 (0.6%)
were detected in South America.

334
335
336
337
338
339
340
341
342
343
344
345
346

Further support for the geographical structuring in the global SARS-CoV-2 populations was
obtained from the DAPC analysis in which we identified four main genetic clusters (Figure
4C). One cluster consisted of a subset of MLGs from each continent, consistent with the
previously described admixture populations in Figure 4B. In contrast, the other three clusters
consisted of MLGs, predominantly from Africa, Asia and North America (Figure 4C). A minor
proportion of MLGs from Oceania showed clinal differentiation into North America (Figure
4B and C), which likely represent closely related SARS-CoV-2 variants that spread between
the two regions [51]. A minor proportion of European and South American MLGs showed
clinal differentiation into the African cluster (Figure 4C). The Gst estimates also supported
evidence of geographical structuring. There was moderate-to-high genetic differentiation (Gst
â‰¥ 0.204) among the continents except between Oceania, separately with Asia and Europe, and
between Europe and South America, where there was little genetic differentiation (Gst â‰¤ 0.079)
(Figure 4D).

347
348
349
350
351
352

Spatial connectivity, including cross-border migrations and international travel, is a major
conduit for spreading the virus (i.e., resulting in gene flow) among countries. Hence, we
expected to see little genetic differentiation among â€˜regional blocksâ€™ within a continent. This
hypothesis was valid for Europe, where there was little to moderate genetic differentiation (Gst
â‰¤ 0.181) among regional blocks except between Eastern and Northern Europe (Gst = 0.248)
(Figure S12). Interestingly, we detected moderate-to-high genetic differentiation (Gst â‰¥ 0.111)
10

medRxiv preprint doi: https://doi.org/10.1101/2021.04.25.21255897; this version posted April 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

353
354
355

among regional blocks in Africa and Asia (Figure S12). This may be a reflection of the fast
and strict travel bans that were put into effect early during the spread of the virus in both
regions.

356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372

Conclusion. The disproportionate distribution of SARS-CoV-2 genomes among the young and
older age groups in this study was representative of the age distribution of COVID-19 cases
reported globally. Throat swabs were the preferred specimen for COVID-19 diagnosis, but the
invasive nature involved in sampling may limit its utility for surveillance. In building a robust
and efficient surveillance system, access to affordable sequencing and rapid analysis of
complex genomic data will be seminal to inform control efforts. The utility of the 74
polymorphic loci as markers for studying the epidemiology and population genetics of SARSCoV-2 infections represents significant progress in developing molecular tools for SARS-CoV2 Surveillance. In particular, the eight informatic loci revealed contrasting epidemiology and
transmission dynamics of the virus among different demographics, geographical regions and
COVID-19 phenotypes. The selection of alleles at these loci and the maintenance of key LD
structures in the infecting genomes indicate that the virus is evolving and adapting resulting in
enhanced transmissibility to humans. An effect of this evolution was the structuring we
observed in the viral population, which allowed us to differentiate closely related variants
between different geographical regions genetically. Future studies can include additional loci
to increase the differentiation among variants within the same geographical region.

373
374
375
376
377
378
379

Limitations. The data presented in this study needs further investigations to draw definite
conclusions on the association between age, gender and geographical region and the SARSCoV-2 variant causing COVID-19. Nearly all the genomes we sampled did not have metadata
on where the patient got infected besides the country where the infection was diagnosed and/or
genome isolated. Thus, it was difficult to infer a source of infection based solely on the MLG
data.

11

medRxiv preprint doi: https://doi.org/10.1101/2021.04.25.21255897; this version posted April 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

380

References

381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.

Lin, Y.-C., et al., The spatiotemporal estimation of the risk and the international transmission of COVID-19: a global
perspective. Scientific Reports, 2020. 10(1): p. 20021.
Romero-Severson, E.O., et al., Change in global transmission rates of COVID-19 through May 6 2020. PLOS ONE, 2020. 15(8):
p. e0236776.
Narh, C.A., Genomic Cues From Beta-Coronaviruses and Mammalian Hosts Sheds Light on Probable Origins and Infectivity of
SARS-CoV-2 Causing COVID-19. Frontiers in Genetics, 2020. 11(902).
Zhu, G., et al., Minireview of progress in the structural study of SARS-CoV-2 proteins. Current Research in Microbial Sciences,
2020. 1: p. 53-61.
Wise, J., Covid-19: New coronavirus variant is identified in UK. BMJ, 2020. 371: p. m4857.
Zhang, L., et al., SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nature
Communications, 2020. 11(1): p. 6013.
Hodcroft, E.B., et al., Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020. medRxiv, 2020:
p. 2020.10.25.20219063.
CDC. Emerging SARS-CoV-2 Variants. 2021 [cited 2021 01 March]; Available from: https://www.cdc.gov/coronavirus/2019ncov/more/science-and-research/scientific-brief-emerging-variants.html.
Yao, H., et al., Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical
implications in vivo. Cell Discovery, 2020. 6(1): p. 76.
Moya, A., E.C. Holmes, and F. GonzÃ¡lez-Candelas, The population genetics and evolutionary epidemiology of RNA viruses.
Nature Reviews Microbiology, 2004. 2(4): p. 279-288.
Forster, P., et al., Phylogenetic network analysis of SARS-CoV-2 genomes. Proc Natl Acad Sci U S A, 2020. 117(17): p. 92419243.
Mercatelli, D. and F.M. Giorgi, Geographic and Genomic Distribution of SARS-CoV-2 Mutations. Frontiers in microbiology,
2020. 11: p. 1800-1800.
Elbe, S. and G. Buckland-Merrett, Data, disease and diplomacy: GISAID's innovative contribution to global health. Global
challenges (Hoboken, NJ), 2017. 1(1): p. 33-46.
Kearse, M., et al., Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of
sequence data. Bioinformatics, 2012. 28(12): p. 1647-1649.
Li, H., Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics, 2018. 34(18): p. 3094-3100.
Kamvar, Z.N., J.F. Tabima, and N.J. GrÃ¼nwald, Poppr: an R package for genetic analysis of populations with clonal, partially
clonal, and/or sexual reproduction. PeerJ, 2014. 2: p. e281.
Oksanen, J., et al., vegan: Community Ecology Package. R package version 2.4-3. Vienna: R Foundation for Statistical
Computing.[Google Scholar], 2016.
Mangin, B., et al., Novel measures of linkage disequilibrium that correct the bias due to population structure and relatedness.
Heredity, 2012. 108(3): p. 285-291.
Garcia, V., et al., Clonal interference can cause wavelet-like oscillations of multilocus linkage disequilibrium. Journal of The
Royal Society Interface, 2018. 15(140): p. 20170921.
Winter, D., MMOD: An R library for the calculation of population differentiation statistics. Molecular Ecology Resources, 2012.
12.
Hedrick, P.W., A Standardized Genetic Differentiation Measure. Evolution, 2005. 59(8): p. 1633-1638.
Jombart, T., S. Devillard, and F. Balloux, Discriminant analysis of principal components: a new method for the analysis of
genetically structured populations. BMC genetics, 2010. 11(1): p. 94.
Jombart, T., adegenet: a R package for the multivariate analysis of genetic markers. Bioinformatics, 2008. 24(11): p. 1403-5.
Wickham, H., ggplot2: elegant graphics for data analysis. J Stat Softw, 2010. 35(1): p. 65-88.
Francisco, A.P., et al., PHYLOViZ: phylogenetic inference and data visualization for sequence based typing methods. BMC
Bioinformatics, 2012. 13(1): p. 87.
RCore, R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Austria, 2015. 2018.
StataCorp, Stata Statistical Software:. 2019.
Ausubel, J., Populations skew older in some of the countries hit hard by COVID-19. Pew Research Center. https://www.
pewresearch. org/fact-tank/2020/04/22/populations-skew-older-in-some-of-the-countries-hit-hard-by-covid-19, 2020.
Davies, N.G., et al., Age-dependent effects in the transmission and control of COVID-19 epidemics. Nature Medicine, 2020.
26(8): p. 1205-1211.
Leung, D.T., et al., Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid.
J Infect Dis, 2004. 190(2): p. 379-86.
van Dorp, L., et al., Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infection, Genetics and Evolution,
2020. 83: p. 104351.
Banerjee, S., et al., Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of
America. Journal of Medical Virology. n/a(n/a).
Pachetti, M., et al., Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant. Journal
of Translational Medicine, 2020. 18(1): p. 179.
Morais, I.J., et al., The global population of SARS-CoV-2 is composed of six major subtypes. Scientific Reports, 2020. 10(1): p.
18289.
van Dorp, L., et al., No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2. Nature
Communications, 2020. 11(1): p. 5986.
Forni, D., et al., Antigenic variation of SARS-CoV-2 in response to immune pressure. Molecular Ecology, 2020. n/a(n/a).
Russell, T.W., et al., Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study.
The Lancet Public Health, 2021. 6(1): p. e12-e20.
Leung, K., et al., Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October
to November 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease
bulletin, 2021. 26(1): p. 2002106.
Zeng, H.-L., et al., Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes.
Proceedings of the National Academy of Sciences, 2020. 117(49): p. 31519-31526.

12

medRxiv preprint doi: https://doi.org/10.1101/2021.04.25.21255897; this version posted April 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472

40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.

Korber, B., et al., Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
Cell, 2020. 182(4): p. 812-827.e19.
McArthur, L., et al., Review of Burden, Clinical Definitions, and Management of COVID-19 Cases. The American journal of
tropical medicine and hygiene, 2020. 103(2): p. 625-638.
Geoghegan, J.L., et al., Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New
Zealand. Nature Communications, 2020. 11(1): p. 6351.
Zhao, Z., et al., Genetic grouping of SARS-CoV-2 coronavirus sequences using informative subtype markers for pandemic spread
visualization. PLOS Computational Biology, 2020. 16(9): p. e1008269.
Poterico, J.A. and O. Mestanza, Genetic variants and source of introduction of SARS-CoV-2 in South America. J Med Virol,
2020. 92(10): p. 2139-2145.
Caccuri, F., et al., A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual. Journal of
Translational Medicine, 2020. 18(1): p. 362.
Islam, M.R., et al., Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity.
Scientific Reports, 2020. 10(1): p. 14004.
Wang, R., et al., Host Immune Response Driving SARS-CoV-2 Evolution. Viruses, 2020. 12(10).
du Plessis, L., et al., Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK. Science, 2021: p. eabf2946.
Sun, H., et al., Importations of COVID-19 into African countries and risk of onward spread. BMC Infectious Diseases, 2020.
20(1): p. 598.
Tegally, H., et al., Sixteen novel lineages of SARS-CoV-2 in South Africa. Nature Medicine, 2021.
Seemann, T., et al., Tracking the COVID-19 pandemic in Australia using genomics. Nature Communications, 2020. 11(1): p.
4376.

473
474
475

13

medRxiv preprint doi: https://doi.org/10.1101/2021.04.25.21255897; this version posted April 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

476

Conflict of Interest

477

None to declare.

478

Author Contributions

479
480
481

CAN, RA and JSR conceived and designed the study. CAN and FC acquired the data and performed
the analysis. CAN and FC drafted the manuscript. RA and JSR critically revised the manuscript. All
authors read and approved the manuscript for publication.

482

Funding

483
484
485
486
487

This work was partly supported by the National Health and Medical Research Council (NHMRC) of
Australia [APP1161076 to JSR]. Burnet Institute received funding from the NHMRC Independent
Research Institutes Infrastructure Support Scheme, and the Victorian State Government Operational
Infrastructure Support Scheme. The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.

488
489
490

Acknowledgements. We are grateful to the authors from the laboratories responsible for obtaining the
specimens and the submitting laboratories where genetic sequence data were generated and shared via
the GISAID Initiative, on which this research is based.

491

14

medRxiv preprint doi: https://doi.org/10.1101/2021.04.25.21255897; this version posted April 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

1
2
3

4
5
6
7
8
9

Figure legends

Figure 1. Spatiotemporal prevalence of eight SARS-CoV-2 mutant alleles and COVID-19 new
cases. The prevalence data for the alleles and newly confirmed cases (WHO report 2020) are
reported for December 2019 to September 2020. Four mutant alleles - ORF1ab L4715, S G614,
and N K203 and R204 were associated with spikes in COVID-19 cases.

1

medRxiv preprint doi: https://doi.org/10.1101/2021.04.25.21255897; this version posted April 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

10
11
12
13
14
15
16

Figure 2. Eight informatic loci in SARS-CoV-2 associated with carriage of mutant alleles
among different age groups, gender, geographical regions and COVID-19 clinical phenotype.
The adjusted odds ratio (OR) with the P-value are shown with orange, blue and grey matrices
indicating OR > 1 and P-value < 0.05, OR < 1 and P-value < 0.05 and 1< OR > 1 and P-value
> 0.05, respectively. The OR was not estimated for study variables with < 5 samples.

2

medRxiv preprint doi: https://doi.org/10.1101/2021.04.25.21255897; this version posted April 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

17
3

medRxiv preprint doi: https://doi.org/10.1101/2021.04.25.21255897; this version posted April 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

18
19
20
21
22
23
24
25
26
27
28
29

30
31
32
33
34
35
36
37
38
39
40
41

Figure 3. Richness in MLG sampling and the standardized index of association (ð‘ŸÌ…d) among
genes in the global SAR-CoV-2 population sampled from December 2019 to September 2020.
A. Rarefaction curve of the MLGs sampled in each geographical region. The plateau in the
curves indicated no new MLGs were detected with further sampling in Africa, Europe, the
American SARS-CoV-2 populations. B. Pairwise LD estimates among genes in the 5,959
genomes sampled globally. The ð‘ŸÌ…d ranges from 0 (no LD) to 1 (complete LD). The values in
the coloured heatmap indicate the P-value associated with the pairwise ð‘ŸÌ…d estimates. The
strongest LD signal (ð‘ŸÌ…d â‰¥ 0.3, P-value < 0.001) was detected between NSP12 and S, NSP1 and
ORF3a, NSP4 and ORF8, and NSP4 and N.

Figure 4. Genetic relatedness and differentiation among SAR-CoV-2 MLGs from different
geographical regions. A. Relatedness among the 472 unique MLGs in the global population.
Eleven clusters including eight global clusters (GC1-8) and three continental clusters â€“ Asia
(AC1-2) and Oceania (OC1) were detected. Nearly all clusters contained a considerable
number of Asian MLGs. B. Population membership assignment of each MLG. Admixture
populations were prominent in all geographical regions. C. DAPC analysis identified one
global cluster (MLGs from all regions, central axis of PCA plot) and three continental clusters
â€“ Africa, Asia and North America. D. Moderate to high genetic differentiation (Neiâ€™s Gst) was
observed among MLGs from different continents.

4

